< Back

November, 2017

Business Model Changes Across Stakeholders Cause Operational Change among Specialty Distributors

Specialty Pharmacy Manager Navigator| November 2017

Business Model Changes Across Stakeholders Cause Operational Change among Specialty Distributors

Business model changes across payers, providers, and biopharmaceutical companies cause operational change among SDs in 2017. Four notable trends immediately impact current SD operations and business development:

  • SPs pursue direct biopharmaceutical company contracts, purposefully eliminating product flow through SDs.
  • Payers and companies narrow their networks, consolidating product dispensing volume to fewer SPs.
  • Industry consolidation and site of care shifts transform SDs' customer base and financial outlook.
  • Payers, providers, and biopharmaceutical companies require more services as value-based care compels SDs to expand offerings to product acquisition customers.

 

These and other findings can be found in Health Strategies Group’s recently released research Specialty Product Management through Specialty Distributors.

Key questions answered in this research:

  • Who are the leading specialty distributors?
  • What market trends are forcing specialty distributors to adjust their specialty product distribution and dispensing strategies?
  • How do services offered by specialty distributors compare and compete with services offered by specialty pharmacies?
  • What key factors should pharmaceutical and biotech companies consider when working with specialty distributors?

 

Visit our Speclty Pharmacy Manager Navigator webpage to learn more about this research.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.